Basic Information
ZYNLONTA® FOR INJECTION 10MG/VIAL
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Regulatory Information
SIN17098P
September 25, 2024
Prescription Only
Therapeutic
INTRAVENOUS
October 8, 2024
June 3, 2025
Company Information
ORIENT EUROPHARMA PTE LTD
Active Ingredients
loncastuximab tesirine
Strength: 10mg/vial